ENTREMED, INC. (ENMD)

ShuntSD (86.80) Submitted: 10/20/06 2:37 PM : Start Price: $2.05 ENMD Score: -53.94

As others say, a gamble with huge upside. But the small molecule research is promising and acquisition was a nice move. Keep close eye on it with stops.

Report this Post Replies: 0 | Reply | Permalink

garupix (28.11) Submitted: 2/06/07 1:09 PM : Start Price: $1.65 ENMD Score: -47.68

Antiangiogenisis is a credible approach to treating cancerous tumors and ENMD pipeline drugs are performing well in Phase II clinical trials.

Report this Post Replies: 0 | Reply | Permalink

hlacheen (98.66) Submitted: 12/21/06 9:39 PM : Start Price: $1.69 ENMD Score: 49.29

Just look at the income statement and cash flow.... this company is a cash-burning disaster, it is NOT worth $120m

Report this Post Replies: 0 | Reply | Permalink

amteague777 (97.80) Submitted: 6/01/07 6:27 PM : Start Price: $1.90 ENMD Score: 45.92

Underperformed s&p since 1996 except for blip in 2000. Negative net income 2004-2007. Currently negative cash flow, ROE, ROA.

Report this Post Replies: 1 | Reply | Permalink

jilbear (45.27) Submitted: 4/15/07 10:50 AM : Start Price: $1.78 ENMD Score: 48.99

This company can only go down from the information available. They are eating cash. This is coming off their second stock offering. It will be years until any of their medications ever hit the market. The bottom line is, this company wont be profitab...

Report this Post Replies: 0 | Reply | Permalink

dwr53 (< 20) Submitted: 4/25/07 8:28 PM : Start Price: $1.79 ENMD Score: -46.75

They have several phase two cancer candidates. Approximately 25% of the shares are owned by Celgene. I suspect they will be taken out by a big pharma looking to improve their pipeline.

Report this Post Replies: 0 | Reply | Permalink

orygunian (66.25) Submitted: 12/15/06 3:12 PM : Start Price: $1.63 ENMD Score: -48.25

More to follow

Report this Post Replies: 0 | Reply | Permalink

dfmxxxxxx (< 20) Submitted: 12/11/06 9:53 PM : Start Price: $1.90 ENMD Score: -50.77

promising pipeline; finally a stream of revenue from Thalomid royalties; good management;

Report this Post Replies: 0 | Reply | Permalink

RRGY2K (78.19) Submitted: 10/28/06 9:30 AM : Start Price: $2.10 ENMD Score: -53.70

With all those clinical trials going on, at least one of them ought to generate some real news soon.

Report this Post Replies: 1 | Reply | Permalink

dorkinglad (< 20) Submitted: 10/27/06 7:11 PM : Start Price: $2.10 ENMD Score: -53.79

Royalties about to kick in big-time. Several promising new drugs in the pipeline. Need for patience.

Report this Post Replies: 0 | Reply | Permalink